All Stories

  1. A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial
  2. A Comparison Between Dexlansoprazole Modified Release–Based And Lansoprazole-Based Nonbismuth Quadruple (Concomitant) Therapy For First-Line Helicobacter pylori Eradication: A Prospective Randomized Trial [Corrigendum]
  3. First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus
  4. Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial
  5. Bridging the Gap between Advancements in the Evolution of Diagnosis and Treatment towards Better Outcomes in Achalasia
  6. Efficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication
  7. Effect of extracorporeal low-energy shock wave on diabetic gastroparesis in a rat model
  8. First-Line Helicobacter pylori Eradication in Patients with Chronic Kidney Diseases in Taiwan
  9. Effect of liquid meals with different volumes on gastroesophageal reflux disease